Skip to main content

Published works by Lorna Tanner

LEX-AR-GD4MQF1Y · complete body of work · page 1 of 1 · 10 works

Published works

2025 Top-of-Mind Issues for Life Sciences Companies
January 31, 2025
LEX-WK-QT6QM8AG
2024 Top-of-Mind Issues for Life Sciences Companies
January 25, 2024
LEX-WK-C42NWEQY
2024 Top-of-Mind Issues for Life Sciences Companies
January 25, 2024
LEX-WK-WVEAXER9
Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term
Intellectual Property Law Blog · May 11, 2021
LEX-WK-09E285JS
Waiver Of Intellectual Property Protections For COVID-19 Vaccine Unlikely To Have Meaningful Impact In Short Term
May 10, 2021
LEX-WK-Q8GJ0FDQ
Federal Circuit Confirms Addition of Two Inventors of Groundbreaking Immunotherapies for Cancer
Intellectual Property Law Blog · July 15, 2020
LEX-WK-YQ280Q44
USPTO Provides Form for Claiming 30-Day COVID-19 Extensions
Intellectual Property Law Blog · May 7, 2020
LEX-WK-5AGMQ3RH
Congress Gives Patent and Trademark Office Temporary Authorization to Move Deadlines in Light of COVID-19 Pandemic
Intellectual Property Law Blog · March 27, 2020
LEX-WK-JJ3Z4XFZ
Federal Circuit Weighs in on Patent Subject-Matter Eligibility of Dietary Supplements
Intellectual Property Law Blog · March 21, 2019
LEX-WK-N9JYH472
PTO Cancer Immunotherapy Fast Track
Intellectual Property Law Blog · July 14, 2016
LEX-WK-A0FW15G0